Setting the Standard in Allergy Diagnostics
In the evolving landscape of allergy diagnostics, precision and reliability are paramount. Thermo Fisher Scientific’s ImmunoCAP™ product range stands out as a gold standard, offering a robust and versatile portfolio tailored to meet the diverse needs of clinicians and patients alike.
Thermo Fisher ImmunoCAP Test Portfolio
At the heart of the ImmunoCAP offering is its Specific IgE test portfolio, which includes
- Over 500 whole allergens and mixes,
- More than 100 allergen components.
This extensive menu allows for detailed differentiation between primary sensitisation and cross-reactivity, enabling clinicians to pinpoint the exact source of allergic reactions. The ImmunoCAP ISAC multiplex test, featuring 112 allergen components on a single chip, further enhances diagnostic capabilities, especially in complex cases.
For early screening, Phadiatop™ and Phadiatop Infant tests provide a reliable indication of atopic allergy, with high sensitivity and specificity. These tests are particularly valuable in pediatric settings, where early detection can significantly influence long-term outcomes.
The Total IgE and Specific IgE tests offer quantitative insights into a patient’s immunological profile. With measuring ranges from 0.1 to 5000 kU/L, these tests support diagnosis and monitoring across conditions such as asthma, rhinitis, and atopic dermatitis. Importantly, ImmunoCAP tests can be performed regardless of age, skin condition, medication use, or pregnancy status—making them suitable for virtually any patient.
Beyond IgE Testing
The portfolio includes Specific IgG and IgG4 tests, which serve as markers for allergen exposure and immunotherapy monitoring. These tests are instrumental in managing conditions like hypersensitivity pneumonitis and evaluating treatment efficacy.
ImmunoCAP’s commitment to high-quality production standards ensures reproducible results and minimal interference, including no risk of anaphylaxis and no biotin interference. This reliability, combined with its broad applicability, makes ImmunoCAP an indispensable tool in modern allergy diagnostics.
Whether you’re seeking to streamline diagnosis, personalise immunotherapy, or enhance patient care, ImmunoCAP delivers the precision and confidence clinicians need.
Explore the full ImmunoCAP portfolio and elevate your allergy diagnostics today.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
